Researchers have identified a four-amino acid peptide, CAQK, that homes in on injured brain tissue when given through a standard IV. In animal studies, it reduced inflammation and cell death while improving recovery, with no major safety issues. The peptide worked in both mice and pigs, bringing it closer to potential human use. Scientists are now preparing steps toward early clinical trials.
